Generally, in all the diverse in vitro inflammation models, resembling PS, HCC and HCC + SH treatments led to a reduction of inflammatory signals in terms of TLR-4, NF-κB and IL-6, IL-23 expression level, also confirmed in 3D model dermal model. The gene discussed is IL23A; the disease is hepatocellular carcinoma.